MEDICA 2022 to Take a Look at New Digital Reality and Revolutionary Technologies
|
By LabMedica International staff writers Posted on 10 Oct 2022 |

As one of the world's leading medical trade fairs, MEDICA (Düsseldorf, Germany) in Düsseldorf presents innovations every year for the entire healthcare workflow, for clinical and outpatients. Among the over 4,200 companies at MEDICA 2022 (duration: 14 – 17 November) there will again be several hundred start-ups. This event, which is one of the most international trade fairs (more than 70% of all visitors hail from abroad, and about 150 nations overall are represented), is a gateway to the world for them, through which they can make contacts across all continents.
One example is the MEDICA CONNECTED HEALTHCARE FORUM (in Hall 12), a special platform for young entrepreneurs. The most important issues of the four-day-program for the year 2022 are: Connected medical things, AI & big data, robotics, the health metaverse, the future of hospitals and care centers, health monitoring and diagnostics, mobile health, digital therapeutics, mental health, and more. About a hundred chosen start-ups and scale-ups present themselves on the forum stage during the MEDICA DISRUPT Sessions. The finale of the 11th MEDICA Start-Up COMPETITION and the "14th Healthcare Innovation World Cup" are highlights of the program.
The 11th MEDICA Start-Up COMPETITION is on the lookout for innovative healthcare industry solutions, from health apps and new tools for gathering and AI-supported analysis of health data, to robotic assistance systems and new approaches in diagnostics. Until mid-September, hundreds of innovators had already registered their participation in the finale of the competition during MEDICA 2022. The 12 best finalists, chosen by a professional jury, will now pitch on 15 November at 1 p.m. to win the grand prize. A day before, on 14 November at 1 p.m., the finale for the "14th Healthcare Innovation World Cup" will start. There, another 12 chosen finalists will pitch to win with their solutions for the "Internet of Medical Things" (IoMT). The span of developments reaches from interconnected medical technological devices, wearable technologies, digital biomarkers and intelligent plasters up to smart implants.
In addition, the metaverse is going to be one of the important topics at the MEDICA CONNECTED HEALTHCARE FORUM. The new buzzword hints at a novel digital reality that focuses on technologies like virtual reality (VR) and augmented reality (AR), the possibilities of processing big data in real time by artificial intelligence, and digital twins. This could lead to revolutionary changes in health care, both for monitoring health and treatments. This trend provides the focus for the content of a symposium, starting on Wednesday, 16 November, at 12 p.m. There, Eva Garcia Ramos, CEO and co-founder of WIVI Vision, will speak. The start-up concentrates mostly on children and adolescents. The products (for example with the capacity for 3D visualization) aim to improve health care with a view to evaluating and treating problems with visual function.
Khora, a Danish start-up, will also be present on stage at the MEDICA CONNECTED HEALTHCARE FORUM. The start-up has worked with the Rigshospitalet to create, for example, an AR universe aimed at children and adolescents from ages ten to fourteen, who have to spend considerable time in hospital with cancer or leukemia. It is supposed to make daily life easier for them. Khora created "Snail Battle", which allows persons affected to use plants to fight against evil monster snails. During the MEDICA CONNECTED HEALTHCARE FORUM, CEO Simon Lajboschitz will also explain, how VR can help patients with schizophrenia affected by auditory hallucinations. The metaverse can offer opportunities in many other areas, ranging from applications for attention deficit disorder over the development and testing of medical devices on virtual patients to simulation scenarios. These will be the focus of talks on Wednesday, 16 November.
Thericon and KuartisMED are among the companies participating in the MEDICA START-UP PARK. The shared booth (also located in Hall 12) has established itself over the years as a central meeting point for business and networking with the young founders' scene, and this year counts around 40 participants. German start-up Thericon see themselves as the first company to bring imaging compiled from several different sources into the operating theatre as a visual aid. Visual representations of hitherto invisible tissue properties are presented together with standard colored images on a single monitor. This diagnostic information and their intuitive display aims to make faster and more precise surgical results possible. The company’s MEDICA START-UP PARK presentation explains how it works in detail. Meanwhile, Turkish company KuartisMED concentrates on innovative solutions for the well-being of newborns. As children born before the 34th week of gestation lack sufficient coordination of the sucking and swallowing reflexes, they depend on feeding tubes for nutrition. The non-invasive medical device by KuartisMED aims to help with evaluating the maturity of these reflexes in the future. These aforementioned examples show that for those interested in innovations in the health sector, a visit to MEDICA 2022, and especially the novelties presented by the various start-ups, is a must.
Related Links:
MEDICA
Latest Industry News
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







